These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8692055)

  • 1. Risks of self-injection therapy for impotence.
    Millard RJ; Stricker PD; Lynch WJ; Dean TE; Murnaghan GF; Breslin FH
    Med J Aust; 1996 Jul; 165(2):117-8. PubMed ID: 8692055
    [No Abstract]   [Full Text] [Related]  

  • 2. [Papaverine-induced priapism. Experiences with a new urologic emergency].
    Schneider AW; Busch R; Gonnermann D; Klosterhalfen H
    Dtsch Med Wochenschr; 1989 Feb; 114(6):214-7. PubMed ID: 2917481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
    Meinhardt W; Lycklama à Nijeholt AA; Kropman RF; Vermeij P; Zwartendijk J
    Eur Urol; 1994; 26(4):319-21. PubMed ID: 7713130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic erection program for the treatment of male impotence.
    Trapp JD
    South Med J; 1987 Apr; 80(4):426-7. PubMed ID: 2436316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence.
    Levine SB; Althof SE; Turner LA; Risen CB; Bodner DR; Kursh ED; Resnick MI
    J Urol; 1989 Jan; 141(1):54-7. PubMed ID: 2908954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metaraminol--an antidote in corpus cavernosum autoinjection therapy-induced prolonged erection].
    Stief CG; Gilbert P; Wetterhauer U; Bähren W; Thon W; Altwein JE
    Urologe A; 1986 May; 25(3):164-5. PubMed ID: 2426857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How safe is the treatment of impotence with intracavernous autoinjection?
    Zentgraf M; Ludwig G; Ziegler M
    Eur Urol; 1989; 16(3):165-71. PubMed ID: 2663519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic roles of intracavernosal papaverine.
    Goldstein I; Payton T; Padma-Nathan H
    Cardiovasc Intervent Radiol; 1988 Aug; 11(4):237-9. PubMed ID: 3147138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients.
    Wyndaele JJ; de Meyer JM; de Sy WA; Claessens H
    Paraplegia; 1986 Oct; 24(5):271-5. PubMed ID: 3774363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiology of erection and pharmacological management of impotence.
    Lue TF; Tanagho EA
    J Urol; 1987 May; 137(5):829-36. PubMed ID: 3553617
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of erectile dysfunction with corpus cavernosum autoinjection and current legal aspects].
    Werner W; Schubert J
    Z Arztl Fortbild (Jena); 1993 Feb; 87(2):165-8. PubMed ID: 8438604
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of prolonged or priapistic erections following intracavernosal papaverine therapy.
    Padma-Nathan H; Goldstein I; Krane RJ
    Semin Urol; 1986 Nov; 4(4):236-8. PubMed ID: 3797893
    [No Abstract]   [Full Text] [Related]  

  • 13. [Priapism as a complication of the treatment of impotence by local injections of papaverine].
    Kaczmarek A
    Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Priapism induced by intracavernous injection].
    Morales Concepción JC
    Arch Esp Urol; 1992 Oct; 45(8):793-5. PubMed ID: 1466580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injection therapy for impotence.
    Kursh ED; Bodner DR; Resnick MI; Althof SE; Turner L; Risen C; Levine SB
    Urol Clin North Am; 1988 Nov; 15(4):625-9. PubMed ID: 3055615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
    [No Abstract]   [Full Text] [Related]  

  • 17. [Priapism following intracavernous injection of vasoactive substances as a urologic emergency].
    Papadopoulos I; Weichert-Jacobsen K; Wand H
    Z Urol Nephrol; 1990 May; 83(5):233-7. PubMed ID: 2392883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients.
    Girdley FM; Bruskewitz RC; Feyzi J; Graversen PH; Gasser TC
    J Urol; 1988 Nov; 140(5):972-4. PubMed ID: 3172370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological erection: diagnosis and treatment applications in 69 patients.
    Nellans RE; Ellis LR; Kramer-Levien D
    J Urol; 1987 Jul; 138(1):52-4. PubMed ID: 2439712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
    Dinsmore WW
    Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.